China probes academic fraud by cancer researchers

June 15, 2017

China is investigating claims of academic fraud involving mostly Chinese cancer researchers after more than 100 articles were withdrawn from a foreign medical journal.

German publisher Springer announced in April the retraction of 107 articles from Tumor Biology after finding evidence the "peer review process was compromised".

The papers had been produced by Chinese medical institutions and universities and published between 2012 and 2016.

It is standard practise for scholars to submit their research to peers for scrutiny before publishing to ensure the integrity of their work, but fraud is a growing problem.

China's Ministry of Science and Technology said it had "zero tolerance" for such behaviour and pledged to investigate "each and every paper retracted".

Researchers involved in the mass retraction have had their projects and funding suspended, it added.

"The incident has had a very bad influence, seriously tarnishing the international reputation of China's scientific circle and hurting the self-esteem of Chinese scientists," the ministry said Wednesday.

"But it also shows we need to strengthen punishment for academic fraud and to improve the academic atmosphere."

The blog Retraction Watch said it had been told by Springer that "the reviews were submitted under the names of real researchers with faked emails. Some of the authors may have used a third-party editing service, which may have supplied the reviews."

Tumor Biology is now published by SAGE Publications in the United States.

It is not the first time Chinese medical experts have been caught faking peer reviews—in 2015 London-based BioMed Central pulled 43 articles, which the Global Times said were mostly by Chinese researchers.

In 2016 Springer retracted 64 articles from 10 journals, many written by Chinese contributors, the newspaper added.

The latest incident highlighted the pressure on Chinese doctors in public hospitals to "publish a certain number of papers in national or international journals just to secure promotion or salary rises", Xinhua news agency said.

Explore further: China issues rules banning dishonesty in science publishing

Related Stories

Publisher retracts 64 articles for fake peer reviews

August 19, 2015

(—German based publishing company Springer has announced on its website that 64 articles published on ten of its journals are being retracted due to editorial staff finding evidence of fake email addresses for ...

Chinese regulators reviewing Uber-Didi merger

September 2, 2016

Chinese anti-monopoly regulators are reviewing the proposed merger of ride-hailing service Uber Technology Ltd.'s Chinese operations with its biggest local competitor.

Recommended for you

How other people affect our interpersonal space

May 24, 2018

Have you ever felt the urge to cross the road or move seats on a train after a conversation taking place nearby suddenly becomes aggressive? Well, for the first time a scientific study has shown how the size of your interpersonal ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.